ArticleClinical kidney journal2019

Daprodustat for anemia: a 24-week, open-label, randomized controlled trial in participants with chronic kidney disease.

Louis Holdstock et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.